Systemic manifestations of T1DM and T2DM differ markedly, substantially due to the selective nature of insulin resistance, which impacts the glucoregulatory effects of insulin without interfering with, and possibly even enhancing, other key actions. The gene discussed is INS; the disease is type 2 diabetes mellitus.